As attendees crowded the Exhibit Hall during the AAP Meeting, Contemporary Pediatrics captured the crowd.
As people crowded the Exhibit Hall during the AAP Meeting, Contemporary Pediatrics captured the scene.
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
September 13th 2024The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.